Clinical Trials Directory

Trials / Completed

CompletedNCT02856204

Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia

Shotgun Sequencing for Etiologic Diagnosis of Febrile Neutropenia

Status
Completed
Phase
Study type
Observational
Enrollment
56 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This research trial studies the shotgun sequencing of blood samples in diagnosing febrile neutropenia in patients with acute myeloid leukemia. Studying samples of blood from patients with acute myeloid leukemia in the laboratory may help identify pathogens and accurately diagnose infections such as febrile neutropenia.

Detailed description

PRIMARY OBJECTIVES: I. To test the hypothesis that shotgun metagenomics is not inferior to standard of care diagnostics in the detection of pathogens in patients with febrile neutropenia. SECONDARY OBJECTIVES: I. To establish a microbiological diagnosis with known or unknown pathogens in patients in whom standard care failed to yield a pathogenic diagnosis. OUTLINE: Patients undergo collection of blood samples before and during the episode of febrile neutropenia for up to 6 weeks.

Conditions

Interventions

TypeNameDescription
OTHERCytology Specimen Collection ProcedureUndergo collection of blood
OTHERLaboratory Biomarker AnalysisCorrelative studies

Timeline

Start date
2016-08-01
Primary completion
2017-12-01
Completion
2019-04-01
First posted
2016-08-04
Last updated
2019-05-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02856204. Inclusion in this directory is not an endorsement.

Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia (NCT02856204) · Clinical Trials Directory